These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 30359860)

  • 1. Epigenetic regulation of hepatic Dpp4 expression in response to dietary protein.
    Saussenthaler S; Ouni M; Baumeier C; Schwerbel K; Gottmann P; Christmann S; Laeger T; Schürmann A
    J Nutr Biochem; 2019 Jan; 63():109-116. PubMed ID: 30359860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic DPP4 DNA Methylation Associates With Fatty Liver.
    Baumeier C; Saussenthaler S; Kammel A; Jähnert M; Schlüter L; Hesse D; Canouil M; Lobbens S; Caiazzo R; Raverdy V; Pattou F; Nilsson E; Pihlajamäki J; Ling C; Froguel P; Schürmann A; Schwenk RW
    Diabetes; 2017 Jan; 66(1):25-35. PubMed ID: 27999105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DPP4 gene DNA methylation in the omentum is associated with its gene expression and plasma lipid profile in severe obesity.
    Turcot V; Bouchard L; Faucher G; Tchernof A; Deshaies Y; Pérusse L; Bélisle A; Marceau S; Biron S; Lescelleur O; Biertho L; Vohl MC
    Obesity (Silver Spring); 2011 Feb; 19(2):388-95. PubMed ID: 20847730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-548ag promotes DPP4 expression in hepatocytes through activation of TLR(7/8)/NF-κB pathway.
    Xiong J; Sun C; Wen X; Hou Y; Liang M; Liu J; Wei Q; Yuan F; Peng C; Chen Y; Chang Y; Wang C; Zhang J
    Int J Obes (Lond); 2024 Jul; 48(7):941-953. PubMed ID: 38424257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of hepatocyte nuclear factor 1b induces hepatic steatosis through DPP4/NOX1-mediated regulation of superoxide.
    Long Z; Cao M; Su S; Wu G; Meng F; Wu H; Liu J; Yu W; Atabai K; Wang X
    Free Radic Biol Med; 2017 Dec; 113():71-83. PubMed ID: 28942246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatocyte-secreted DPP4 in obesity promotes adipose inflammation and insulin resistance.
    Ghorpade DS; Ozcan L; Zheng Z; Nicoloro SM; Shen Y; Chen E; Blüher M; Czech MP; Tabas I
    Nature; 2018 Mar; 555(7698):673-677. PubMed ID: 29562231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in Expression of DPP4 in Steatotic Rat Liver Are Not Related to Differences in the Methylation of its Gene Promoter.
    Tarantola E; Gobbato S; Ferrigno A; Bertone V; Capelli E
    In Vivo; 2015; 29(5):547-53. PubMed ID: 26359413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A siRNA mediated hepatic dpp4 knockdown affects lipid, but not glucose metabolism in diabetic mice.
    Görgens SW; Jahn-Hofmann K; Bangari D; Cummings S; Metz-Weidmann C; Schwahn U; Wohlfart P; Schäfer M; Bielohuby M
    PLoS One; 2019; 14(12):e0225835. PubMed ID: 31794591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic Glucose Metabolism Disorder Induced by Adipose Tissue-Derived miR-548ag via DPP4 Upregulation.
    Chu X; Hou Y; Zhang X; Li M; Ma D; Tang Y; Yuan C; Sun C; Liang M; Liu J; Wei Q; Chang Y; Wang C; Zhang J
    Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered dipeptidyl peptidase-4 activity during the progression of hyperinsulinemic obesity and islet atrophy in spontaneously late-stage type 2 diabetic rats.
    Kirino Y; Sato Y; Kamimoto T; Kawazoe K; Minakuchi K
    Am J Physiol Endocrinol Metab; 2011 Feb; 300(2):E372-9. PubMed ID: 21139073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating Levels of Soluble Dipeptidyl Peptidase-4 Are Dissociated from Inflammation and Induced by Enzymatic DPP4 Inhibition.
    Varin EM; Mulvihill EE; Beaudry JL; Pujadas G; Fuchs S; Tanti JF; Fazio S; Kaur K; Cao X; Baggio LL; Matthews D; Campbell JE; Drucker DJ
    Cell Metab; 2019 Feb; 29(2):320-334.e5. PubMed ID: 30393019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beneficial Effects of Evogliptin, a Novel Dipeptidyl Peptidase 4 Inhibitor, on Adiposity with Increased Ppargc1a in White Adipose Tissue in Obese Mice.
    Chae YN; Kim TH; Kim MK; Shin CY; Jung IH; Sohn YS; Son MH
    PLoS One; 2015; 10(12):e0144064. PubMed ID: 26633898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Grape seed-derived procyanidins decrease dipeptidyl-peptidase 4 activity and expression.
    González-Abuín N; Martínez-Micaelo N; Blay M; Pujadas G; Garcia-Vallvé S; Pinent M; Ardévol A
    J Agric Food Chem; 2012 Sep; 60(36):9055-61. PubMed ID: 22891874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Degradation of Incretins and Modulation of Blood Glucose Levels by Periodontopathic Bacterial Dipeptidyl Peptidase 4.
    Ohara-Nemoto Y; Nakasato M; Shimoyama Y; Baba TT; Kobayakawa T; Ono T; Yaegashi T; Kimura S; Nemoto TK
    Infect Immun; 2017 Sep; 85(9):. PubMed ID: 28630069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of circulatory DPP4 activity in metabolic diseases.
    Nargis T; Chakrabarti P
    IUBMB Life; 2018 Feb; 70(2):112-119. PubMed ID: 29331088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liraglutide alters DPP4 in the circumvallate papillae of type 2 diabetic rats.
    Cao X; Zhou X; Liu XM; Zhou LH
    J Mol Endocrinol; 2016 Jul; 57(1):13-21. PubMed ID: 27151572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular Sites and Mechanisms Linking Reduction of Dipeptidyl Peptidase-4 Activity to Control of Incretin Hormone Action and Glucose Homeostasis.
    Mulvihill EE; Varin EM; Gladanac B; Campbell JE; Ussher JR; Baggio LL; Yusta B; Ayala J; Burmeister MA; Matthews D; Bang KWA; Ayala JE; Drucker DJ
    Cell Metab; 2017 Jan; 25(1):152-165. PubMed ID: 27839908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DA-1229, a novel and potent DPP4 inhibitor, improves insulin resistance and delays the onset of diabetes.
    Kim MK; Chae YN; Kim HD; Yang EK; Cho EJ; Choi SH; Cheong YH; Kim HS; Kim HJ; Jo YW; Son MH; Kim SH; Shin CY
    Life Sci; 2012 Jan; 90(1-2):21-9. PubMed ID: 22056373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dipeptidyl Peptidase IV as a Prognostic Marker and Therapeutic Target in Papillary Thyroid Carcinoma.
    Lee JJ; Wang TY; Liu CL; Chien MN; Chen MJ; Hsu YC; Leung CH; Cheng SP
    J Clin Endocrinol Metab; 2017 Aug; 102(8):2930-2940. PubMed ID: 28575350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic role in an early glucose-lowering effect by a novel dipeptidyl peptidase 4 inhibitor, evogliptin, in a rodent model of type 2 diabetes.
    Kim TH; Kim MK; Cheong YH; Chae YN; Lee Y; Ka SO; Jung IH; Shin CY; Bae EJ; Son MH
    Eur J Pharmacol; 2016 Jan; 771():65-76. PubMed ID: 26621343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.